Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37 + lymphoid malignancies

Blood (2024) 144 (11): 1153–1167.

https://doi.org/10.1182/blood.2024024104

Published: 2024

Includes: Supplemental data

Journal Articles

Low-frequency inherited complement receptor variants are associated with purpura fulminans

Blood (2024) 143 (11): 1032–1044.

https://doi.org/10.1182/blood.2023021231

Published: 2024

Includes: Supplemental data

Journal Articles

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma

Blood (2022) 140 (16): 1822–1826.

https://doi.org/10.1182/blood.2022015443

Published: 2022

Includes: Multimedia, Supplemental data

Journal Articles

Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway

Blood (2021) 138 (23): 2435–2440.

https://doi.org/10.1182/blood.2021012536

Published: 2021

Includes: Supplemental data

Journal Articles

Molecular Features and Clinical Outcomes of Extramedullary Plasmacytomas

Rie Nakamoto-Matsubara, Valentina Nardi, Cristina Panaroni, Keertik Fulzele, Tomoaki Mori, Rakesh Verma, Andrew J. Yee, Andrew R. Branagan, Elizabeth O'Donnell, Noopur S. Raje

Blood (2021) 138 (Supplement 1): 398.

https://doi.org/10.1182/blood-2021-152784

Published: 2021

Journal Articles

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk

Orly Leiva, MD, Olesya Baker, PhD, Andrew M. Brunner, Hanny Al-Samkari, MD, Rebecca Karp Leaf, MD, Rachel P. Rosovsky, MD MPH, Amir T. Fathi, MD, James I Weitzman, MD, Larissa Bornikova, MD, Valentina Nardi, MD, Gabriela S. Hobbs, MD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-137311

Published: 2020

Journal Articles

Rare Inherited Defects of the Complement System in Purpura Fulminans

Pavan Bendapudi, MD, Justine Ryu, MD, Onuralp Soylemez, Betty Rouaisnel, Meaghan Colling, MD, Bryce Pasko, Alissa Robbins, Michael Bouzinier, Lindsay Tomczak, Sanjay Ram, Agnes Toth-Petroczy, Joel Krier, Elizabeth Fieg, Walter Dzik, MD, James Hudspeth, MD, Olga Pozdnyakova, MD PhD, Valentina Nardi, MD, Richard Maas, Julie-Aurore Losman, MD PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-138729

Published: 2020

Journal Articles

Targeted FGFR Inhibition Results in Hematologic and Cytogenetic Remission in a Myeloid Neoplasm Driven By a Novel PCM1-FGFR1 Fusion: Data from an Expanded Access Program

Monica Kasbekar, Valentina Nardi, MD, Paola Dal Cin, Andrew M. Brunner, MD, Yi-Bin Chen, Christine Connolly, Amir T. Fathi, MD, Julia Foster, ANP, Molly Macrae, Steven L McAfee, MD, Kristin McGregor, Rupa Narayan, Aura Y. Ramos, Tina T. Som, RN, Megan Vartanian, RN, Robb S Friedman, MD, Karim Benhadji, MD MSC, Gabriela S. Hobbs, MD

Blood (2019) 134 (Supplement_1): 5371.

https://doi.org/10.1182/blood-2019-124100

Published: 2019

Journal Articles

Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera

Chi-Joan How, MD, Orly Leiva, BS, Thomas Bogue, BS, Geoffrey Fell, MS, Mark Bustoros, MD, Nathan T. Connell, MD MPH, Jean M. Connors, MD, Irene M. Ghobrial, MD, Nancy Higgins, Nicholas A Jessop, David J. Kuter, Jennifer Lombardi Story, Ann Mullally, MD, Valentina Nardi, MD, Donna S Neuberg, ScD, Rachel Styles, BS, Jeffrey I. Zwicker, MD, Gabriela S. Hobbs, MD, Annemarie E Fogerty, MD

Blood (2019) 134 (Supplement_1): 4172.

https://doi.org/10.1182/blood-2019-127058

Published: 2019

Journal Articles

Clinical, Immunophenotypic and Genomic Findings of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow Pathology Group

Olga K Weinberg, MD, Robert P. Hasserjian, MD, Ezra Baraban, MD, Chi Young Ok, MD, Julia T Geyer, MD, John KSS Philip, MD, Jason H. Kurzer, MD PhD, Heesun J. Rogers, MD PhD, Valentina Nardi, MD, Richard M. Stone, MD, Jacqueline S. Garcia, Eric D. Hsi, MD, Adam Bagg, MD, Sa A. Wang, MD, Attilio Orazi, MD, Daniel A. Arber, MD

Blood (2018) 132 (Supplement 1): 1491.

https://doi.org/10.1182/blood-2018-99-115198

Published: 2018

Journal Articles

High NPM1 -mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML

Sanjay S. Patel, Frank C. Kuo, Christopher J. Gibson, David P. Steensma, Robert J. Soiffer, Edwin P. Alyea, III, Yi-Bin A. Chen, Amir T. Fathi, Timothy A. Graubert, Andrew M. Brunner, Martha Wadleigh, Richard M. Stone, Daniel J. DeAngelo, Valentina Nardi, Robert P. Hasserjian, Olga K. Weinberg

Blood (2018) 131 (25): 2816–2825.

https://doi.org/10.1182/blood-2018-01-828467

Published: 2018

Includes: Supplemental data

Journal Articles

Notch-Regulated Enhancers in B-Cell Lymphoma Activate MYC and Potentiate B-Cell Receptor Signaling

Russell J.H. Ryan, MD, Jelena Petrovic, PhD, Dylan Rausch, BS, Caleb Lareau, BS, Winston Lee, MD PhD, Laura Donohue, BS, Amanda L. Christie, BS, Shawn Gillespie, BS, Michael J. Kluk, MD PhD, Valentina Nardi, MD, Robert B. Faryabi, PhD, Ephraim P. Hochberg, MD, David M. Weinstock, MD, Bradley E. Bernstein, MD PhD, Jon C. Aster, MD PhD, Warren S. Pear, MD PhD

Blood (2016) 128 (22): 457.

https://doi.org/10.1182/blood.V128.22.457.457

Published: 2016

Journal Articles

Peptides Derived From Mutated BCR-ABL Elicit T Cell Immunity In CML Patients

Ann Cai, Derin Keskin, Anselmo Alonso, David DeLuca, Wandi Zhang, Naa Lokko, Valentina Nardi, Richard M Stone, M.D., John Sidney, Vladimir Brusic, Catherine J Wu, MD

Blood (2010) 116 (21): 887.

https://doi.org/10.1182/blood.V116.21.887.887

Published: 2010

Journal Articles

ICSBP-mediated immune protection against BCR-ABL–induced leukemia requires the CCL6 and CCL9 chemokines

Valentina Nardi, Olaia Naveiras, Mohammad Azam, George Q. Daley

Blood (2009) 113 (16): 3813–3820.

https://doi.org/10.1182/blood-2008-07-167189

Published: 2009

Includes: Supplemental data

Journal Articles

Bone Marrow Adipocytes Prevent Hematopoietic Expansion in Homeostasis and in Bone Marrow Transplantation

Olaia Naveiras, M.D., Valentina Nardi, MD, George Q. Daley, MD, PhD

Blood (2008) 112 (11): 551.

https://doi.org/10.1182/blood.V112.11.551.551

Published: 2008

Journal Articles

A Critical Role for CCL Chemokines in the Immuno-Protection Induced by Type I Interferons and IRF8/ICSBP Against Bcr/Abl-Induced Leukemia.

Valentina Nardi, MD, Olaia Naveiras, MD, Mohammad Azam, PhD, George Q. Daley, MD, PhD

Blood (2007) 110 (11): 1001.

https://doi.org/10.1182/blood.V110.11.1001.1001

Published: 2007

Journal Articles

Bone Marrow Adipocytes: A Novel Negative Regulator of the Hematopoietic Microenvironment.

Olaia Naveiras, MD, Valentina Nardi, MD, Parul Sharma, PhD, Peter Hauschka, PhD, George Q. Daley, MD, PhD

Blood (2007) 110 (11): 1405.

https://doi.org/10.1182/blood.V110.11.1405.1405

Published: 2007

Journal Articles

Farnesyl transferase inhibitor resistance probed by target mutagenesis

Tal Raz, Valentina Nardi, Mohammad Azam, Jorge Cortes, George Q. Daley

Blood (2007) 110 (6): 2102–2109.

https://doi.org/10.1182/blood-2006-12-064907

Published: 2007

Includes: Supplemental data

Journal Articles

Monitoring Imatinib Resistance with a “Polony” Assay: Towards Tailored Therapy of Chronic Myelogenous Leukemia (CML).

Valentina Nardi, MD, Tal Raz, PhD, Xinyu Chao, Catherine J. Wu, MD, Richard Stone, MD, Ilene Galinsky, RN, NP, Martha Wadleigh, MD, Michael W.N. Deininger, MD, PhD, George Church, PhD, Jun Zhu, PhD, George Q. Daley, MD, PhD

Blood (2006) 108 (11): 837.

https://doi.org/10.1182/blood.V108.11.837.837

Published: 2006

Journal Articles

BCR-ABL Kinase Dynamics and Drug Resistance.

Mohammad Azam, PhD, Valentina Nardi, MD, William C. Shakespear, PhD, Robert R. Latek, PhD, Darren Veach, PhD, Bernard Clarckson, PhD, Regine Bohacheck, PhD, Tomi K. Sawyer, PhD, George Q. Daley, MD, PhD

Blood (2005) 106 (11): 1996.

https://doi.org/10.1182/blood.V106.11.1996.1996

Published: 2005

NARROW

Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37 + lymphoid malignancies

Low-frequency inherited complement receptor variants are associated with purpura fulminans

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma

Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway

Molecular Features and Clinical Outcomes of Extramedullary Plasmacytomas

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk

Rare Inherited Defects of the Complement System in Purpura Fulminans

Targeted FGFR Inhibition Results in Hematologic and Cytogenetic Remission in a Myeloid Neoplasm Driven By a Novel PCM1-FGFR1 Fusion: Data from an Expanded Access Program

Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera

Clinical, Immunophenotypic and Genomic Findings of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow Pathology Group

High NPM1 -mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML

Notch-Regulated Enhancers in B-Cell Lymphoma Activate MYC and Potentiate B-Cell Receptor Signaling

Peptides Derived From Mutated BCR-ABL Elicit T Cell Immunity In CML Patients

ICSBP-mediated immune protection against BCR-ABL–induced leukemia requires the CCL6 and CCL9 chemokines

Bone Marrow Adipocytes Prevent Hematopoietic Expansion in Homeostasis and in Bone Marrow Transplantation

A Critical Role for CCL Chemokines in the Immuno-Protection Induced by Type I Interferons and IRF8/ICSBP Against Bcr/Abl-Induced Leukemia.

Bone Marrow Adipocytes: A Novel Negative Regulator of the Hematopoietic Microenvironment.

Farnesyl transferase inhibitor resistance probed by target mutagenesis

Monitoring Imatinib Resistance with a “Polony” Assay: Towards Tailored Therapy of Chronic Myelogenous Leukemia (CML).

BCR-ABL Kinase Dynamics and Drug Resistance.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only